Company Filing History:
Years Active: 2001
Title: The Innovations of Sharon Bingham in Neuropathic Treatments
Introduction
Sharon Bingham, an accomplished inventor based in Saffron Walden, GB, has made significant strides in the field of medical science with her innovative work in neuropathy treatments. With a single patent to her name, she has dedicated her efforts to improving the understanding and treatment of various neurological conditions.
Latest Patents
Sharon Bingham holds a patent related to KIAA0551 polynucleotides and polypeptides. This invention focuses on the use of KIAA0551 polypeptides and polynucleotides in creating protocols for treating neuropathies, neuropathic pain, inflammatory and chronic pain, and neurodegenerative conditions, including Motor Neuron Disease, Parkinson's Disease, Alzheimer’s Disease, and other dementias. Moreover, her invention also addresses ischaemic damage in neuronal and cardiac tissues, which may arise from diseases or infectious agents. The patent further discloses methods for producing these polypeptides using recombinant techniques, showcasing a promising advancement in therapeutic strategies.
Career Highlights
Sharon is associated with SmithKline Beecham Corporation, where she continues to contribute to the field of medical innovations. Her work has garnered attention for its potential impact on treating debilitating neurological disorders, making her a key figure in the ongoing research for effective therapies.
Collaborations
In her professional journey, Sharon has collaborated with eminent colleagues such as Patrick Case and Sally Neale Lawson. These collaborations highlight the importance of teamwork in pioneering research and development in medical science, allowing for a multifaceted approach to tackling complex health issues.
Conclusion
Sharon Bingham's contributions to the fields of neurology and biotechnology underscore the vital role of innovation in addressing health challenges. Her patent on KIAA0551 polynucleotides and polypeptides is a testament to her dedication and expertise, with the potential to transform treatment protocols for a range of neurological conditions. As researchers and practitioners continue to build upon her work, the future of neuropathic pain treatment looks promising.